Roche (OTCMKTS:RHHBY) Stock Passes Below Fifty Day Moving Average – Here’s What Happened

Roche Holding AG (OTCMKTS:RHHBY)’s share price crossed below its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of $50.77 and traded as low as $48.83. Roche shares last traded at $49.00, with a volume of 1,914,382 shares traded.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Wolfe Research reaffirmed an “outperform” rating on shares of Roche in a research note on Thursday, February 26th. Argus raised shares of Roche from a “hold” rating to a “buy” rating in a research note on Monday, April 6th. TD Cowen reaffirmed a “hold” rating on shares of Roche in a research note on Tuesday, February 10th. Finally, Morgan Stanley raised shares of Roche from an “underweight” rating to an “equal weight” rating and set a $46.00 target price for the company in a research note on Friday, April 24th. Five equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $51.50.

Roche Price Performance

The company’s 50 day moving average price is $50.89 and its 200-day moving average price is $52.31. The company has a current ratio of 1.38, a quick ratio of 1.12 and a debt-to-equity ratio of 0.72.

Institutional Trading of Roche

Several institutional investors have recently made changes to their positions in RHHBY. Altrius Capital Management Inc grew its stake in shares of Roche by 4.0% during the 3rd quarter. Altrius Capital Management Inc now owns 198,278 shares of the company’s stock valued at $8,290,000 after buying an additional 7,659 shares during the period. S&CO Inc. grew its stake in shares of Roche by 1.9% during the 3rd quarter. S&CO Inc. now owns 52,154 shares of the company’s stock valued at $2,129,000 after buying an additional 955 shares during the period. PNC Financial Services Group Inc. grew its stake in shares of Roche by 23.0% during the 3rd quarter. PNC Financial Services Group Inc. now owns 18,799 shares of the company’s stock valued at $786,000 after buying an additional 3,513 shares during the period. Vestmark Advisory Solutions Inc. purchased a new stake in shares of Roche during the 3rd quarter valued at $597,000. Finally, Curio Wealth LLC purchased a new stake in shares of Roche during the 3rd quarter valued at $25,000.

About Roche

Roche Holding AG is a Swiss multinational healthcare company headquartered in Basel, founded in 1896 by Fritz Hoffmann?La Roche. The company operates primarily through two complementary divisions — Pharmaceuticals and Diagnostics — and is known for integrating drug development with diagnostic capabilities to advance personalized healthcare. In the United States and other international markets, shares trade as American Depositary Receipts under the ticker RHHBY (OTCMKTS:RHHBY).

In pharmaceuticals, Roche focuses on developing and commercializing prescription medicines across therapeutic areas including oncology, immunology, infectious diseases and neuroscience, with a notable emphasis on targeted biologics and personalized therapies.